J
Jonathan W. Said
Researcher at University of California, Los Angeles
Publications - 446
Citations - 27211
Jonathan W. Said is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Lymphoma & Cancer. The author has an hindex of 78, co-authored 437 publications receiving 25399 citations. Previous affiliations of Jonathan W. Said include University of California & Sanford-Burnham Institute for Medical Research.
Papers
More filters
Journal ArticleDOI
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
TL;DR: A high degree of conservation of KSHV sequences in Kaposi's sarcoma and in the eight lymphomas suggests the presence of the same agent in both lesions, suggesting that a novel herpesvirus has a pathogenic role in AIDS-related body-cavity-based lymphomas.
Journal ArticleDOI
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.
E Elstner,Claudia I. Muller,K Koshizuka,Elizabeth A. Williamson,Dorothy J. Park,H Asou,P Shintaku,Jonathan W. Said,David Heber,H P Koeffler +9 more
TL;DR: The combination of TGZ and ATRA synergistically and irreversibly inhibits growth and induces apoptosis of MCF7 breast cancer cells and the combination may provide a novel, nontoxic and selective therapy for human breast cancers.
Journal ArticleDOI
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
Young E. Whang,Xinyi Wu,Hiroyoshi Suzuki,Robert E. Reiter,Chris Tran,Robert L. Vessella,Jonathan W. Said,William B. Isaacs,Charles L. Sawyers +8 more
TL;DR: It is demonstrated that loss of PTEN/MMAC1 expression occurs frequently in advanced prostate cancer by using a series of recently derived xenografts free of normal human cells and a PTEN/.
Journal ArticleDOI
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Amnon Zisman,Allan J. Pantuck,Fredrick Dorey,Jonathan W. Said,Oleg Shvarts,Deanna Quintana,Barbara J. Gitlitz,Jean B. deKernion,Robert A. Figlin,Arie S. Belldegrun +9 more
TL;DR: The data suggests that UISS is an important prognostic tool for counseling patients with various stages of kidney cancer and is superior to stage alone in differentiating patients' survival.
Journal Article
Ligand for Peroxisome Proliferator-activated Receptor γ (Troglitazone) Has Potent Antitumor Effect against Human Prostate Cancer Both in Vitro and in Vivo
Tetsuya Kubota,K Koshizuka,Elizabeth A. Williamson,H Asou,Jonathan W. Said,Stuart Holden,Isao Miyoshi,H P Koeffler +7 more
TL;DR: Results suggest that troglitazone may be a useful therapeutic agent for the treatment of prostate cancer, especially in the setting of low disease burden.